Zobrazeno 1 - 10
of 37
pro vyhledávání: '"Candace, Hsieh"'
Autor:
Daniela A. Bota, Thomas H. Taylor, David E. Piccioni, Christopher M. Duma, Renato V. LaRocca, Santosh Kesari, Jose A. Carrillo, Mehrdad Abedi, Robert D. Aiken, Frank P. K. Hsu, Xiao-Tang Kong, Candace Hsieh, Peter G. Bota, Gabriel I. Nistor, Hans S. Keirstead, Robert O. Dillman
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 41, Iss 1, Pp 1-9 (2022)
Abstract Background Vaccine immunotherapy may improve survival in Glioblastoma (GBM). A multicenter phase II trial was designed to determine: (1) the success rate of manufacturing the Aivita GBM vaccine (AV-GBM-1), (2) Adverse Events (AE) associated
Externí odkaz:
https://doaj.org/article/5a31d54aac0647619b0bae78c1eddb03
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Thomas Taylor, Mehrdad Abedi, Xiaotang Kong, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/880199fb78a646b7bc992874e012370a
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/8f9a84d2159c4de8b1710c03af1984ef
Autor:
Gabriel Nistor, Robert Dillman, Aleksandra Poole, Daniela Bota, David Piccioni, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Xiao-Tang Kong, Thomas Taylor, Mehrdad Abedi, Candace Hsieh
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/cb2068f08fb04b3f882fb1d7137e7e73
Autor:
Gabriel Nistor, Robert Dillman, Daniela Bota, Christopher Duma, Renato LaRocca, Santosh Kesari, Jose Carrillo, Robert Aiken, Frank Hsu, Thomas Taylor, Mehrdad Abedi, Candace Hsieh, David Piccione, Xiang-Tang Kong
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/85d119ddf7e04730ba9f587c01ad54ec
Artificial Differences in Clostridium difficile Infection Rates Associated with Disparity in Testing
Autor:
Mini Kamboj, Jennifer Brite, Anoshe Aslam, Jessica Kennington, N. Esther Babady, David Calfee, Yoko Furuya, Donald Chen, Michael Augenbraun, Belinda Ostrowsky, Gopi Patel, Monica Mircescu, Vivek Kak, Roman Tuma, Teresa A. Karre, Deborah A. Fry, Yola P. Duhaney, Amber Moyer, Denise Mitchell, Sherry Cantu, Candace Hsieh, Nancy Warren, Stacy Martin, Jill Willson, Jeanne Dickman, Julie Knight, Kim Delahanty, Annemarie Flood, Jennifer Harrington, Deborah Korenstein, Janet Eagan, Kent Sepkowitz
Publikováno v:
Emerging Infectious Diseases, Vol 24, Iss 3, Pp 584-587 (2018)
In 2015, Clostridium difficile testing rates among 30 US community, multispecialty, and cancer hospitals were 14.0, 16.3, and 33.9/1,000 patient-days, respectively. Pooled hospital onset rates were 0.56, 0.84, and 1.57/1,000 patient-days, respectivel
Externí odkaz:
https://doaj.org/article/44d90c5f72814f668d040474ed21cd09
Autor:
Robert Owen Dillman, Candace Hsieh
Publikováno v:
Biomedicines, Vol 7, Iss 4, p 80 (2019)
Encouraging survival was observed in single arm and randomized phase 2 trials of patient-specific dendritic cell vaccines presenting autologous tumor antigens from autologous cancer cells that were derived from surgically resected metastases whose ce
Externí odkaz:
https://doaj.org/article/e50d2c18007e48a2b2b5f77864699630
Autor:
Meghan A Baker, Chanu Rhee, Robert Tucker, Amy Badwaik, Cassie Coughlin, Meghan A Holtzman, Candace Hsieh, Angela Maguire, Elizabeth Mermel Blaeser, Saranya Seetharaman, Ofelia Solem, Vineeta Vaidya, Michael Klompas
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 75(1)
The highly contagious severe acute respiratory syndrome coronavirus 2 Omicron variant increases risk for nosocomial transmission despite universal masking, admission testing, and symptom screening. We report large increases in hospital-onset infectio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0530d3f3eaf585f71ec5e8e6d48da42
https://pubmed.ncbi.nlm.nih.gov/35445253
https://pubmed.ncbi.nlm.nih.gov/35445253
Autor:
Renato V. LaRocca, Robert O Dillman, Gabriel Nistor, Mehrdad Abedi, Jose Carrillo, Thomas H. Taylor, Frank P.K. Hsu, Christopher Duma, Robert Aiken, Santosh Kesari, David Piccioni, Candace Hsieh, Xiao-Tang Kong, Daniela A. Bota
Publikováno v:
Neuro Oncol
Neuro-Oncology, vol 23, iss Supplement_6
Neuro-Oncology, vol 23, iss Supplement_6
In primary glioblastoma (GBM), overall survival (OS) is poor despite standard aggressive therapy. Adjunctive AV-GBM-1 vaccine immunotherapy may improve OS. In this multi-institutional phase II trial, key eligibility criteria for intent-to-treat (ITT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6bc93a34830b30cc812ef84e13606b8
https://europepmc.org/articles/PMC8598812/
https://europepmc.org/articles/PMC8598812/
Autor:
Thomas H. Taylor, Renato V. LaRocca, Daniela A. Bota, Jose Carrillo, Mehrdad Abedi, Robert O. Dillman, David Piccioni, Xiao-Tang Kong, Candace Hsieh, Gabriel Nistor, Christopher Duma, Robert Aiken, Santosh Kesari, Frank P.K. Hsu
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
BackgroundStandard therapy of glioblastoma (GBM), which includes maximum safe resection, concurrent radiation therapy and temozolomide chemotherapy (RT/TMZ) followed by maintenance TMZ, is associated with poor overall survival (OS). Adding treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42cbd609fdf83a1c1ab4e005e9fa669f
https://doaj.org/article/880199fb78a646b7bc992874e012370a
https://doaj.org/article/880199fb78a646b7bc992874e012370a